Skip to main content

The Oncology Institute to Open Project Southland

Written by Customer Service on . Posted in Mergers And Acquisitions.

TOI acquires SRON and expands radiation oncology services in the Greater LA area

CERRITOS, Calif., June 07, 2023 (GLOBE NEWSWIRE) — The Oncology Institute (NASDAQ: TOI), has announced a strategic acquisition that aims to further consolidate the Greater Los Angeles market and establish the company as one of the largest value-based community oncology groups in the United States. The acquisition of Southland Radiation Oncology Network (SRON) will amplify TOI’s radiation oncology market presence by five additional clinics across the eastern San Gabriel Valley and Inland Empire, providing TOI with a distinct advantage over local private practices and tertiary centers.

The acquisition of SRON is an important milestone for TOI as they continue to expand their ability to provide complete population health for oncology care. It will enable broader coverage across the Los Angeles area, providing more access to life-saving care for those who may not be able to otherwise afford treatment or transportation.

“We are thrilled to be taking this next step in our journey as we expand our radiation oncology practice locations, and look forward to serving the community with the highest quality of care,” said Dan Virnich, MD, MBA, FACHE, President of The Oncology Institute. “This acquisition aligns with our strategic vision to be the leading value-based cancer care group in the U.S., and demonstrates our commitment to delivering comprehensive oncology solutions that will benefit our patients and the broader community.”

The acquisition of SRON will enable TOI to offer value-based radiation oncology care to more patients in the Greater Los Angeles area.

About TOI
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 700 teammates in over 60 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Media

The Oncology Institute, Inc.
Daniel Virnich, MD
danielvirnich@theoncologyinstitute.com
(562) 735-3226 x 81125

Investors

Solebury Strategic Communications
investors@theoncologyinstitute.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.